Europe Biomaterials Market

The Europe biomaterials market is expected to reach USD 21.59 billion by 2030 from USD 15.21  billion in 2025, at a CAGR of 7.3%. The growth of the Europe biomaterials market is  driven by increasing incidence of chronic conditions and strong public healthcare systems and well-established medical device manufacturing base.

Several key players in the Europe biomaterials industry include BASF SE (Germany), Covestro AG (Germany), Corbion NV (Netherlands), DSM (Netherlands), Evonik Industries AG (Germany), Victrex PLC (UK), CeramTec GmbH (Germany), and GELITA AG (Germany), among others. Companies in this market are adopting expansion strategies to strengthen their global footprint and advance their technology portfolios. In February 2025,  BASF launched HySorb B 6610 ZeroPCF, the first polyacrylate-based superabsorbent polymer marketed with a product carbon footprint of zero for hygiene and medical absorbent products.

To know about the assumptions considered for the study download the pdf brochure

BASF SE (GERMANY)

BASF is a leading materials supplier in the Europe biomaterials market, offering a broad range of medical grade polymers and superabsorbent materials that support safer, more reliable implants, wound care products, and medical devices. The company's Ultrason and Ultraform/Ultradur PRO families deliver high heat resistance, biocompatibility, and sterilization stability for reusable surgical instruments, device housings, and single use components.

Covestro AG (Germany)

Covestro AG is a key biomaterials supplier in Europe, offering Baymedix medical polyurethanes and Platilon TPU films for advanced wound dressings, wearable patches, and soft medical devices. These materials deliver breathability, absorption, skin adhesion, and sterilization resistance, helping OEMs design comfortable, durable products for chronic-wound management and connected health monitoring.

Corbion NV (Netherlands)

Corbion NV specializes in PURASORB bioresorbable PLA and PLGA polymers used in long-acting drug-delivery depots, resorbable orthopedic fixation, and regenerative-medicine scaffolds. Its medical-grade polymers offer precise control of degradation and release profiles, strong regulatory pedigree, and robust GMP manufacturing, making Corbion a preferred partner for complex combination products and tissue-engineering solutions.

Market Ranking

The Europe biomaterials market is underpinned by a small group of influential chemical and materials companies, with BASF, Covestro, Corbion, DSM, and Evonik Industries shaping how advanced polymers, bioresorbables, and high-performance fibers move from lab concepts into commercial implants and drug-delivery systems. BASF supplies medical-grade superabsorbent polymers and hydrogels used in wound dressings, surgical pads, and fluid-management products, while Covestro’s Baymedix polyurethanes and Platilon TPU films enable breathable dressings, wearable patches, and skin-contact devices. Corbion’s PURASORB PLA/PLGA portfolio anchors the region’s bioresorbable implant and long-acting injectable space, DSM provides ultra-strong Dyneema Purity UHMWPE fibers for orthopedic and cardiovascular devices, and Evonik’s RESOMER bioresorbable polymers support a wide range of orthopedic, dental, and cardiovascular implants, increasingly distributed through specialized partners across Europe.

Related Reports:

Europe Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic Acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com